Prognostic and clinical impact of PD-L2 and PD-L1 expression in a cohort of 437 oesophageal cancers

BACKGROUND: The PD-1/PD-L1 pathway plays critical roles in tumour immunology, and serves as an immune-based therapeutic target. Less is known regarding PD-L2, another ligand of PD-1, and its relation to clinical outcome in human cancers. METHODS: We used a database of 437 surgically and 100 endoscop...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Br J Cancer
Main Authors: Okadome, Kazuo, Baba, Yoshifumi, Nomoto, Daichi, Yagi, Taisuke, Kalikawe, Rebecca, Harada, Kazuto, Hiyoshi, Yukiharu, Nagai, Yohei, Ishimoto, Takatsugu, Iwatsuki, Masaaki, Iwagami, Shiro, Miyamoto, Yuji, Yoshida, Naoya, Watanabe, Masayuki, Komohara, Yoshihiro, Shono, Takashi, Sasaki, Yutaka, Baba, Hideo
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7217865/
https://ncbi.nlm.nih.gov/pubmed/32210369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-0811-0
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares